BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 8053717)

  • 1. Melanoma risk in individuals with clinically atypical nevi.
    Kang S; Barnhill RL; Mihm MC; Fitzpatrick TB; Sober AJ
    Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
    Schneider JS; Moore DH; Sagebiel RW
    Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
    Risser J; Pressley Z; Veledar E; Washington C; Chen SC
    J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
    Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
    Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects.
    Nordlund JJ; Kirkwood J; Forget BM; Scheibner A; Albert DM; Lerner E; Milton GW
    Cancer Res; 1985 Apr; 45(4):1855-61. PubMed ID: 3978645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of surveillance programme aimed at early diagnosis of cutaneous melanoma in high risk Mediterranean subjects.
    Carli P; Balzi D; de Giorgi V; Massi D; Palli D; Chiarugi A; Nardini P; Giannotti B
    Eur J Dermatol; 2003; 13(5):482-6. PubMed ID: 14693495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study.
    Marghoob AA; Kopf AW; Rigel DS; Bart RS; Friedman RJ; Yadav S; Abadir M; Sanfilippo L; Silverman MK; Vossaert KA
    Arch Dermatol; 1994 Aug; 130(8):993-8. PubMed ID: 8053716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysplastic vulvar nevi.
    Blickstein I; Feldberg E; Dgani R; Ben-Hur H; Czernobilsky B
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):968-70. PubMed ID: 1923241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From sporadic atypical nevi to familial melanoma: risk analysis for melanoma in sporadic atypical nevus patients.
    de Snoo FA; Kroon MW; Bergman W; ter Huurne JA; Houwing-Duistermaat JJ; van Mourik L; Snels DG; Breuning MH; Willemze R; Frants RR; Gruis NA
    J Am Acad Dermatol; 2007 May; 56(5):748-52. PubMed ID: 17276542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.
    Hansson J; Bergenmar M; Hofer PA; Lundell G; Månsson-Brahme E; Ringborg U; Synnerstad I; Bratel AT; Wennberg AM; Rosdahl I
    J Clin Oncol; 2007 Jul; 25(19):2819-24. PubMed ID: 17602087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic spectrum of clinically atypical melanocytic nevi. II. Studies of nonfamilial melanoma.
    Barnhill RL; Roush GC
    Arch Dermatol; 1990 Oct; 126(10):1315-8. PubMed ID: 2221935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dysplastic nevi and the risk of melanoma: a guideline for patient care. Nederlandse Melanoom Werkgroep van de Vereniging voor Integrale Kankercentra].
    Bergman W; van Voorst Vader PC; Ruiter DJ
    Ned Tijdschr Geneeskd; 1997 Oct; 141(42):2010-4. PubMed ID: 9550752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysplastic nevus--risk factor or disguise for melanoma.
    Dediol I; Bulat V; Zivković MV; Marković BM; Situm M
    Coll Antropol; 2011 Sep; 35 Suppl 2():311-3. PubMed ID: 22220461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined melanocytic nevi: histologic variants and melanoma mimics.
    Baran JL; Duncan LM
    Am J Surg Pathol; 2011 Oct; 35(10):1540-8. PubMed ID: 21881487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
    Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
    Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with the prevalence of atypical nevus in a Mediterranean pigmented skin lesion clinic.
    Lasithiotakis KG; Kokolakis A; Giannikaki E; Krasagakis K; Tosca A
    Melanoma Res; 2011 Oct; 21(5):469-73. PubMed ID: 21760555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Family studies on the incidence of multiple pigmented naevi, familial skin melanoma and other malignant tumors].
    Szekeres L; Korom I
    Orv Hetil; 1991 Sep; 132(39):2153-6. PubMed ID: 1923488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grading of atypia in nevi: correlation with melanoma risk.
    Arumi-Uria M; McNutt NS; Finnerty B
    Mod Pathol; 2003 Aug; 16(8):764-71. PubMed ID: 12920220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.